Independent CRO Upsell MSC positions itself as an independent CRO partner for established, startup, and virtual companies, offering feasibility studies through preclinical prep and long-term support. This creates sales opportunities to engage biotech startups and small to mid-size biotechs seeking outsourced R&D and process development.

GPP and Inductive Risk Reduction New GPP Services provide a menu-driven approach to reduce risk and add predictability for GMP production campaigns, including full downstream process development and unit operations. A sales angle is offering risk-mitigated CMO or co-development partnerships for IND-readiness.

Mable Capabilities Match MSC’s core strengths in purification, characterization of mAbs and recombinant proteins, downstream processing, formulation, fill-finish, and tech transfer align with sponsor needs transitioning from discovery to GMP manufacturing. This supports cross-selling into clients needing end-to-end CRO to CMO support.

Strategic Location Edge An ISO8 facility in Marlborough MA with access to the Boston biotech hub, plus insured operations and IP-secure documentation, enhances credibility for risk-averse clients and offers a compelling onsite presence for collaborations and pilot runs near major biotech networks.

Founder Experience Signal Gary McNeil’s long industry background since 1990 and track record as a founder and patent holder for a medical device startup signal reliability and deep expertise, making MSC attractive for partners seeking seasoned leadership and dependable delivery on complex projects.